SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Thursday reported a loss of $27.9 million in its fiscal third quarter.
On a per-share basis, the San Francisco-based company said it had a loss of 92 cents.
The maker of synthetic DNA for the biotechnology industry posted revenue of $13.6 million in the period, surpassing Street forecasts. Three analysts surveyed by Zacks expected $12.5 million.
Twist Bioscience expects full-year revenue in the range of $52 million to $53 million.
Twist Bioscience shares have risen 40% since the beginning of the year.